Structurally unique PARP‐1 inhibitors for the treatment of prostate cancer

• প্রধান লেখক: Ali Divan (লেখক), Mukund P. Sibi (লেখক), Alexei Tulin (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Wiley, 2020-04-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract The prognosis for metastatic castration‐resistant prostate cancer is unfavorable, and although Poly(ADP)‐ribose polymerase‐1 (PARP‐1) inhibitors have shown efficacy in the treatment of androgen‐receptor dependent malignancies, the limited number of options present obstacles for patients tha...